Two months after demonetisation, companies seem more positive now...
Speaking to company managements may not be very fruitful. Investors should focus on trends in retail sales in their conversations with the companies. Demonetisation is unprecedented and has no global parallels. Our channel checks indicate that at the bottom of the demonetisation trough, sales were down 60–70 per cent for several businesses. Anecdotes can be misleading more than they usually are. Investors need to be far more data-focused now. Demonetisation is not an event we can get ahead of. I suspect the numbers will not look as bad as anecdotal references suggest.
How long would the period of waiting be?
We estimate that much of the cash should be replaced by February. The risk is in extrapolating the effects of demonetisation based on the status quo as the pain could be relieved by government policy action. Investors are therefore logically expecting a fiscally stimulating Budget in February. The government has managed to reduce the fiscal deficit to 3.5 per cent. There is, however, an argument that deficits could be counter-cyclically increased. The government may choose some degree of fiscal stimulus to support growth after demonetisation. If this happens, demand in rural-focused businesses such as consumer staples could improve sooner than expected. But uncertainty in recovery for the discretionary sectors like auto and paints is likely higher.
But car sales have been reasonably good so far...
Yes, the numbers were better than expected but the margins driven by discounts would be the key to profitability this quarter. My fear is that consumer behaviour on discretionary consumption will take longer to heal as the government policy is unlikely to be focused on reviving urban discretionary demand. We advise investors to be overweight on banks, consumer staples and cement; which is where we expect earnings to improve. In the case of banks, the December quarter could mark the end of year-on-year profit declines. From the March quarter, banks should report improved profits supported by the low base of last year. We don’t advise seeking inexpensive value stocks now, but prefer to look for sectors where earnings are likely to recover or grow.
What about IT and health care, which are being viewed as defensives now?
We are underweight on IT. While valuations are supportive, event risks in the sector are currently high. If the US government were to increase visa fees, the impact on earnings could be very material. We would prefer to wait for clarity on policies of the new US administration, even if it means that we review our position on the IT sector when the share prices are higher than they are now. Top down, we prefer the pharma space over IT, although the pharmaceutical sector in India is more about bottom-up stock picking. We believe utilities may do well in the current environment not because of their defensive qualities but due to reduction in interest rates.
So with fewer pockets showing growth now, do you see a further valuation correction for the market as a whole?
Market valuations have been de-linked from growth prospects in India for the past five years. Price-earning (PE) multiples for India have moved in tandem with emerging markets (EMs). Much of the recent recovery in the markets have to do with the increase in EM stock prices and are perhaps only partly due to a review of the assessment of demonetisation. The uncertainty due to demonetisation may not drive Indian equity valuations lower. Despite uncertainties around demonetisation and the GST, we expect Indian equities to deliver positive returns. Our Sensex target for the end of December is 29,000.
There is also a view that developed markets are becoming more attractive now than earlier...
Yes, higher fixed-income returns in US dollars reduce investor attraction for emerging markets. However, increasing rates may shift some investment from bonds to equities. Most EMs have reduced external deficits since the taper tantrum and may be able to better withstand global shocks. We believe EMs are in a much better shape than they were in three years ago and should continue to deliver decent growth for investors.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)